Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, De Witte Jan, holds the title of Director at RESMED INC.
On 2026-11-17, the insider transacted 429 shares.The shares were transacted at a weighted average price of $237.00 per share, resulting in a total market-relevant value of $102K.
De Witte Jan (Director) sold $102K of $RMD
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.